158 related articles for article (PubMed ID: 18690390)
1. Overactivated mitogen-activated protein kinase by anisomycin induces tau hyperphosphorylation.
Wang Q; Zhang JY; Liu SJ; Li HL
Sheng Li Xue Bao; 2008 Aug; 60(4):485-91. PubMed ID: 18690390
[TBL] [Abstract][Full Text] [Related]
2. Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain.
Liu SJ; Zhang JY; Li HL; Fang ZY; Wang Q; Deng HM; Gong CX; Grundke-Iqbal I; Iqbal K; Wang JZ
J Biol Chem; 2004 Nov; 279(48):50078-88. PubMed ID: 15375165
[TBL] [Abstract][Full Text] [Related]
3. A transitory activation of protein kinase-A induces a sustained tau hyperphosphorylation at multiple sites in N2a cells-imply a new mechanism in Alzheimer pathology.
Zhang Y; Li HL; Wang DL; Liu SJ; Wang JZ
J Neural Transm (Vienna); 2006 Oct; 113(10):1487-97. PubMed ID: 16465464
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
[TBL] [Abstract][Full Text] [Related]
6. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.
Liu SJ; Zhang AH; Li HL; Wang Q; Deng HM; Netzer WJ; Xu H; Wang JZ
J Neurochem; 2003 Dec; 87(6):1333-44. PubMed ID: 14713290
[TBL] [Abstract][Full Text] [Related]
7. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM
Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741
[TBL] [Abstract][Full Text] [Related]
9. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
10. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
11. tau kinases in the rat heat shock model: possible implications for Alzheimer disease.
Shanavas A; Papasozomenos SC
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14139-44. PubMed ID: 11121021
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
[TBL] [Abstract][Full Text] [Related]
13. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.
Avila J; Wandosell F; Hernández F
Expert Rev Neurother; 2010 May; 10(5):703-10. PubMed ID: 20420491
[TBL] [Abstract][Full Text] [Related]
14. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
[TBL] [Abstract][Full Text] [Related]
15. Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease.
Papasozomenos SCh; Shanavas A
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1140-5. PubMed ID: 11805297
[TBL] [Abstract][Full Text] [Related]
16. In vitro analysis of tau phosphorylation sites and its biological activity.
Wang J; Wang X; Liu R; Wang Q; Grundke-Iqbal I; Iqbal K
Chin Med Sci J; 2002 Mar; 17(1):13-6. PubMed ID: 12894878
[TBL] [Abstract][Full Text] [Related]
17. Prolonged Alzheimer-like tau hyperphosphorylation induced by simultaneous inhibition of phosphoinositol-3 kinase and protein kinase C in N2a cells.
Xu GG; Deng YQ; Liu SJ; Li HL; Wang JZ
Acta Biochim Biophys Sin (Shanghai); 2005 May; 37(5):349-54. PubMed ID: 15880264
[TBL] [Abstract][Full Text] [Related]
18. Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo.
Lu J; Miao J; Su T; Liu Y; He R
Biochim Biophys Acta; 2013 Aug; 1830(8):4102-16. PubMed ID: 23628704
[TBL] [Abstract][Full Text] [Related]
19. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
[TBL] [Abstract][Full Text] [Related]
20. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
